Definitely a merger. Is this a good thing or bad thing for MMS holder. That is, did MMS overpay for Eclipx or was it fair price? They said within 3 years, value of this transaction will be worth it? Am I interpreting this correctly?
- Forums
- ASX - By Stock
- Ann: Trading Halt
Definitely a merger. Is this a good thing or bad thing for MMS...
Featured News
Add MMS (ASX) to my watchlist
(20min delay)
|
|||||
Last
$15.35 |
Change
-0.050(0.32%) |
Mkt cap ! $1.069B |
Open | High | Low | Value | Volume |
$15.30 | $15.52 | $15.13 | $4.097M | 267.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 147 | $15.35 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.45 | 3498 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 147 | 15.350 |
1 | 249 | 15.310 |
3 | 3331 | 15.290 |
1 | 1500 | 15.240 |
2 | 21 | 15.230 |
Price($) | Vol. | No. |
---|---|---|
15.450 | 3498 | 3 |
15.520 | 1082 | 2 |
15.550 | 7155 | 3 |
15.600 | 1893 | 1 |
15.750 | 200 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
MMS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online